At the end of last week, fund managers had built up the largest net long position in crude oil futures in nine months, according to data from the Commodity Futures Trading Commission. It is serving as a necessary inflation hedge given a growing conflict in the Middle East, and declining drilling at home.

LOS ANGELES--(BUSINESS WIRE)---- $WOOF--WOOF Investors Have Opportunity to Join Petco Health and Wellness Company, Inc. Fraud Investigation with the Schall Law Firm.

SAN DIEGO , June 22, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities between February 27, 2025 and May 26, 2025, all dates inclusive (the "Class Period"), have until August 11, 2025 to seek appointment as lead plaintiff of the Rocket Pharmaceuticals class action lawsuit. Captioned Ho v.

Ventas is a healthcare REIT focused on senior housing, outpatient medical & research, and triple net properties. The company increased its FFO guidance as senior housing continues to benefit from higher occupancy and improved margins. Indeed, I estimate that Ventas may see a NOI boost as high as $190 million should robust senior housing performance continue.

LOS ANGELES--(BUSINESS WIRE)---- $NPCE--NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm.

Cash flows across the energy sector tend to be more variable due to commodity price volatility . However, some energy stocks just print money because their business models have minimal direct exposure to commodity prices.

Cathie Wood's Ark Invest has been one of the most vocal supporters of and investors in Tesla (TSLA -0.09%), and it's no secret in the investing world that Ark has a $2,600 price target on the stock for 2029. Still, what does that target mean, and does Ark's reasoning make sense?

Hamilton Beach Brands has improved revenue and profitability, aided by the HealthBeacon acquisition and favorable product mix, despite recent share price underperformance. Tariff concerns and US-China trade tensions are weighing on sentiment, but the company is actively diversifying manufacturing away from China to mitigate risk. The stock is attractively valued compared to peers, with a strong balance sheet and minimal net debt, providing resilience during near-term challenges.

ProShares UltraPro Russell2000 targets 3x daily returns of the Russell 2000 Index, but actual returns can deviate significantly over time. Holding leveraged ETFs beyond one day exposes investors to compounding effects and beta slippage, especially in volatile markets. Beta slippage can cause leveraged ETF returns to underperform or outperform the expected multiple, depending on volatility and holding period.

These are broadly the paths forward in the wake of the U.S. decision to join Israel's war on Iran.

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.

Circle CEO, Chairman and co-founder Jeremy Allaire details IPO excitement, high-utility stablecoin, the GENIUS Act's 'excellent' points and the state of America's macroeconomy in a wide-ranging interview. #FOXBusiness

Its latest 3 top picks suggest more gains to come.

Kraft Heinz (KHC) announced plans to remove artificial colors from its products. The company's goal is to stop using all synthetic dyes in US products by 2027.

Zscaler's strong Q3 FY25 results, platform expansion, and growing enterprise adoption support my raised price target of $373, implying 23% upside. The company's Zero Trust Everywhere, Data Security, and Agentic Operations initiatives are driving deeper platform adoption and larger enterprise deals. The new Z-Flex purchasing program enhances customer flexibility and is already boosting bookings, positioning Zscaler well amid macroeconomic uncertainty.

Archer Aviation's $850M stock offering is a strategic move to strengthen liquidity ahead of eVTOL commercialization, despite short-term stock volatility. The timing of the capital raise is prudent, leveraging recent stock momentum and reducing future funding risk, even if it surprised some investors. Proceeds will fund infrastructure, the Launch Edition program, Olympic air taxi services, and AI aviation software, supporting Archer's long-term growth.

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) resulting from allegations that GeneDx may have issued materially misleading business information to the investing public.

Oil prices were expected to climb, but stocks could also get a boost. Israel's stock market hit a record on Sunday.

NCR Atleos Management have outlined an impressive, understandable, and highly believable strategy for earnings growth. The company and the stock are at a possible inflection point. Now is possibly an opportune time for investment in the shares of this stock.

CLSE has a long/short equity strategy designed to profit from both winners positioned to gain and laggards forecast to decline. Since its conversion to an ETF in 2022, it has delivered solid gains, outperforming IVV and IWV, chiefly thanks to its ability to keep losses at bay in 2022. I believe CLSE's nimble strategy should work for the current environment, as the U.S. airstrikes on Iran's nuclear facilities can contribute to volatility in the high-priced market.